Abstract

In order to investigate Rev-1 vaccination immunogenicity, 60 indigenous (Makuii) non-infected female lambs 3–4 months of age in northwestern Iran were systematically divided into two groups: 40 into a treatment (T) group and 20 into a control (C) group. Lambs in Group T received 1 ml of Rev-1 vaccine by s.c. injection and blood samples were collected from both groups at 15 days and 2, 4, 6, 8, 10, 12 and 14 months after vaccination. The seroagglutination test (SAT) and the 2-mercaptoethanol test (2-MET) were carried out on the sera. Control lambs were negative in all the examinations. The results of the SAT showed that the mean( ± SD) antibody titre of lambs in Group T was maximum (725 ± 112 IUml −1) at Day 15, then declined gradually until the fourth month and was in the normal range (31 IU ml −1) thereafter. The results of the 2-MET were negative in Group C but in Group T the antibody titre was at a maximum level (161.7 ± 46.6 IUml −1) at Day 15, decreased to 1.2 ± 2.5IUml −1 at 4 months post-vaccination and was negativ; thereafter. In the second part of the trial, 20 vaccinated and ten control lambs received 0.25 ml melitin by i.d. injection 10.5 months after vaccination. The control group showed no reaction but 13 (65%) of the vaccinated lambs showed an oedematous swelling at the site of injection within 48 h, which indicated that the delayed-type hypersensitivity test (DTHT) could be useful in the diagnosis of Brucella infection in lambs. In the third stage of the experiment, four vaccinated and three control lambs were injected with Brucella melitensis strain 16M at a rate of more than 123 × 10 6 bacteria per lamb 14 months after vaccination. Rectal temperature (Tem), heart-rate ( HR) and respiration rate ( RR) were measured three times a day (at 08:00, 14:00 and 21:00 h) 3 days before until 9 days after injection. SAT was carried out on the day before injection and at the time of slaughter. The mean Tem, HR and RR did not significantly change but the mean( ± SD) SAT titre in the T lambs 9 days after injection was 47.5 ± 9.9 IU ml −1 (vs. 8.66 ±6.1 IU ml −1 in the control lambs) ( P < 0.01). All lambs were slaughtered on the ninth day. Fewer bacterial cultures of samples taken from the uterus, spleen, liver and lymph nodes were positive in T lambs compared with the controls. The lower proportion of Brucella-positive lambs in the vaccinated group compared with the control group indicates that vaccination with Rev-1 improved the resistance of lambs to the experimental infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call